Harrisburg, Pa. — Some Pennsylvania cannabis companies are using incomplete or misleading claims to promote marijuana as a treatment for opioid addiction, potentially putting patients’ lives at greater risk, a Spotlight PA investigation has found.
In a first-of-its-kind review, Spotlight PA examined more than 60 websites offering services in Pennsylvania and consulted numerous health policy experts about the validity of the claims.
In some instances where medical research was cited on a website or by a company official, the news organization directly contacted study authors.
Continue reading on northcentralpa.com